Caption Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-305,400
Closed -$5.63M 1558
2025
Q3
$5.63M Buy
305,400
+276,500
+957% +$4.44M 0.04% 451
2025
Q2
$376K Buy
+28,900
New +$342K ﹤0.01% 1181
2025
Q1
Sell
-30,000
Closed -$509K 1499
2024
Q4
$509K Buy
+30,000
New +$565K ﹤0.01% 1103
2024
Q3
Sell
-60,000
Closed -$1.46M 1260
2024
Q2
$1.46M Sell
60,000
-25,000
-29% -$758K 0.02% 556
2024
Q1
$2.87M Buy
85,000
+25,000
+42% +$886K 0.04% 439
2023
Q4
$1.89M Buy
60,000
+30,000
+100% +$713K 0.03% 632
2023
Q3
$767K Buy
+30,000
New +$924K 0.01% 841
2023
Q2
Sell
-30,000
Closed -$719K 1091
2023
Q1
$719K Buy
+30,000
New +$538K 0.01% 704
2022
Q4
Sell
-30,000
Closed -$444K 1263
2022
Q3
$444K Hold
30,000
0.01% 1094
2022
Q2
$472K Buy
+30,000
New +$589K 0.01% 1087

Other funds holding ARCT